B. Lynne Parshall

2017

In 2017, B. Lynne Parshall earned a total compensation of $5.4M as Former Chief Operating Officer at Ionis Pharmaceuticals, a 2% decrease compared to previous year.

Compensation breakdown

Bonus$668,909
Option Awards$2,968,317
Salary$734,056
Stock Awards$942,853
Other$45,902
Total$5,360,037

Parshall received $3M in option awards, accounting for 55% of the total pay in 2017.

Parshall also received $668.9K in bonus, $734.1K in salary, $942.9K in stock awards and $45.9K in other compensation.

Rankings

In 2017, B. Lynne Parshall's compensation ranked 1,710th out of 14,666 executives tracked by ExecPay. In other words, Parshall earned more than 88.3% of executives.

ClassificationRankingPercentile
All
1,710
out of 14,666
88th
Division
Manufacturing
575
out of 5,768
90th
Major group
Chemicals And Allied Products
151
out of 2,074
93rd
Industry group
Drugs
109
out of 1,730
94th
Industry
Pharmaceutical Preparations
87
out of 1,329
94th
Source: SEC filing on April 26, 2019.

Parshall's colleagues

We found five more compensation records of executives who worked with B. Lynne Parshall at Ionis Pharmaceuticals in 2017.

2017

Stanley Crooke

Ionis Pharmaceuticals

Chief Executive Officer

2017

Brett Monia

Ionis Pharmaceuticals

Chief Operating Officer

2017

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

2017

Patrick O'Neil

Ionis Pharmaceuticals

General Counsel

2017

Elizabeth Hougen

Ionis Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like